Physician profile
David J Rodricks
NPI 1275579138
$6,512.95
in general payments reported to CMS, 2019-2025
18 companies · $4,812 in 2025
The $4,812 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $136 · 2021: $224 · 2022: $242 · 2023: $226 · 2024: $643 · 2025: $4,812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,125 · Food and Beverage: $1,103 · Travel and Lodging: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,125.00 |
| Food and Beverage | $1,102.84 |
| Travel and Lodging | $453.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,049.86 | 2019-2025 | Journey II, Real Intelligence, Journey II Xr |
| Zimmer Biomet Holdings, INC. | $513.51 | 2019-2025 | Persona, Gel-One Cross-Linked Hyaluronate |
| Ferring Pharmaceuticals INC. | $239.48 | 2019-2025 | Euflexxa |
| La Jolla Pharmaceutical Company | $211.09 | 2023-2024 | |
| Depuy Synthes Sales INC. | $117.32 | 2019-2025 | Orthovisc, Monovisc |
| Stryker Corporation | $65.65 | 2022 | |
| Bioventus LLC | $60.21 | 2024 | Durolane |
| Baxter Healthcare | $41.47 | 2021 | |
| Heraeus Medical, LLC. | $38.67 | 2024 | |
| Davol INC. | $32.52 | 2021 | |
| Intellijoint Surgical INC. | $30.34 | 2021 | |
| Avanos Medical | $22.04 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.85 | 2021 | |
| Fidia Pharma USA INC. | $15.71 | 2024 | Hymovis |
| Kowa Pharmaceuticals America, INC. | $14.96 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ebi, LLC | $14.47 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $14.47 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Zyla Life Sciences, INC. | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rodricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.